MedTrace Logo

Clinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Participants With Glycogen Storage Disease Type III

NCT05196165 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2023-09-28

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the incidence of hypoglycemia in adult and pediatric participants with glycogen storage disease type III (GSD III).

Conditions

  • Glycogen Storage Disease Type III

Interventions

OTHER

No Intervention

No investigational product (IP) will be administered in this study

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Ultragenyx Pharmaceutical Inc

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-20
Primary Completion
2023-03-02
Completion
2023-03-02

Countries

  • United States
  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05196165 on ClinicalTrials.gov